Graham Capital Management, L.P. Enanta Pharmaceuticals Inc Transaction History
Graham Capital Management, L.P.
- $5.17 Billion
- Q2 2025
A detailed history of Graham Capital Management, L.P. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Graham Capital Management, L.P. holds 18,730 shares of ENTA stock, worth $203,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,730
Previous 20,022
6.45%
Holding current value
$203,407
Previous $110,000
28.18%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
18.7MCall Options Held
50KPut Options Held
0-
Farallon Capital Management LLC San Francisco, CA2.12MShares$23 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.11MShares$23 Million8.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$21.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$20.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.46MShares$15.8 Million0.01% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $225M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...